CANESTEN 3 DAY INTERNAL CREAM 2 %
CLOTRIMAZOLE : 2 % · DIN 02150905 · BAYER INC
Health Canada status: MARKETED
What is CANESTEN 3 DAY INTERNAL CREAM?
CANESTEN 3 DAY INTERNAL CREAM 2 % contains CLOTRIMAZOLE : 2 %. It is listed in the Health Canada Drug Product Database under DIN 02150905, held by BAYER INC, supplied as CREAM for VAGINAL administration. Health Canada currently lists it as marketed, status dated 09-Nov-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CANESTEN 3 DAY INTERNAL CREAM used for?
Treatment of vaginal candidiasis (yeast infection) and topical treatment of external irritation caused by vulvovaginal candidiasis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02150905 |
|---|---|
| Brand name | CANESTEN 3 DAY INTERNAL CREAM |
| Generic / active ingredient | CLOTRIMAZOLE : 2 % |
| Manufacturer | BAYER INC |
| Strength | 2 % |
| Dosage form | CREAM |
| Route of administration | VAGINAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | G01AF02 CLOTRIMAZOLE |
| AHFS class | 84:04.08.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 09-Nov-2018 |
| Original market date | 1995-12-31 00:00:00 |
How is it administered?
Vaginal: 1 full applicator, 1 tablet, or 1 capsule intravaginally for 1, 3, or 6 days depending on product. External: Apply to irritated area 1-2 times daily for up to 7 days.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store between 15°C - 30°C. Specific 1-day products: store between 15°C - 25°C.
How is it supplied?
Tubes (5g, 10g, 15g, 20g, 25g, 50g), blister packs for tablets/capsules, and kits containing both internal and external treatments.
Contraindications
Hypersensitivity to clotrimazole or to any ingredient in the formulation, including any non-medicinal ingredient, or component of the container.
Warnings and precautions
Not for oral or ophthalmic use. Seek medical advice if infections are frequent (more than every 2 months) or if immunocompromised. Discontinue if skin sensitization occurs.
What can be used instead?
Other Canadian products sharing ATC code G01AF02 CLOTRIMAZOLE. 19 of 36 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CANESTEN 1 DAY INTERNAL CREAM | 10 % | CREAM | BAYER INC | MARKETED | DIN 02150883 |
| CANESTEN 6 DAY INTERNAL CREAM | 1 % | CREAM | BAYER INC | MARKETED | DIN 02150891 |
| CANESTEN COMBI 1 DAY | 1 % | CREAM ; VAGINAL TABLET ; KIT | BAYER INC | MARKETED | DIN 02264102 |
| CANESTEN COMBI 1 DAY INTERNAL + EXTERNAL CREAMS | 10 % | KIT ; CREAM | BAYER INC | MARKETED | DIN 02230509 |
| CANESTEN COMBI 1 DAY SOFT CAPSULE + EXTRA STRENGTH EXTERNAL CREAM | 500 MG | KIT ; VAGINAL CAPSULE ; CREAM | BAYER INC | MARKETED | DIN 02547260 |
| CANESTEN COMBI 3 DAY | 200 MG | KIT ; VAGINAL TABLET ; CREAM | BAYER INC | MARKETED | DIN 02264099 |
| CANESTEN COMFORTAB 1 | 500 MG | VAGINAL TABLET | BAYER INC | MARKETED | DIN 02150859 |
| CANESTEN COMFORTAB 3 | 200 MG | VAGINAL TABLET | BAYER INC | MARKETED | DIN 02150840 |
| CANESTEN EXTERNAL CREAM | 1 % | CREAM | BAYER INC | MARKETED | DIN 02311720 |
| CANESTEN EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM | 2 % | CREAM | BAYER INC | MARKETED | DIN 02490927 |
Who else supplies CLOTRIMAZOLE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CLOTRIMAZOLE appears in 169 registered pack listings across 10 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.